Opioid Therapies and Cytochrome P450 Interactions

被引:48
|
作者
Gudin, Jeffrey [1 ]
机构
[1] Englewood Hosp & Med Ctr, Pain Management & Wellness Ctr, Englewood, NJ 07631 USA
关键词
Adverse drug reactions; cytochrome P450; CYP3A4; CYP2D6; drug-drug interactions; inhibitor; inducer; metabolism; prodrug; substrate; opioids; DRUG-DRUG INTERACTIONS; ST-JOHNS-WORT; CAFFEINE METABOLISM; PHARMACOGENETICS; INHIBITION; CYP2D6; PAIN; VARIABILITY; HYDROCODONE; OXYMORPHONE;
D O I
10.1016/j.jpainsymman.2012.08.013
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Adverse drug reactions are common and associated with substantial economic and human costs. Particularly among older adult populations, preventable adverse drug reactions are often caused by drug-drug interactions. All analgesics have side effect profiles and many have known drug-drug interactions. Opioids are recognized as a necessary option for managing moderate-to-severe pain, yet many opioid side effects can be enhanced by metabolic interactions within the liver, involving other drugs, diseases, or genetics. J Pain Symptom Manage 2012; 44: S4-S14. (C) 2012 U. S. Cancer Pain Relief Committee. Published by Elsevier Inc. All rights reserved.
引用
收藏
页码:S4 / S14
页数:11
相关论文
共 50 条
  • [1] Human Cytochrome P450 Interactions with Redox Partner Cytochrome P450 Reductase
    Burris-Hiday, Sarah
    Chai, Mengqi
    Gross, Michael L.
    Scott, Emily
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2023, 385
  • [2] Opioid Metabolism and Effects of Cytochrome P450
    Holmquist, Gregory L.
    PAIN MEDICINE, 2009, 10 : S20 - S29
  • [3] Interactions of herbs with cytochrome P450
    Zhou, SF
    Gao, YH
    Jiang, WQ
    Huang, M
    Xu, AL
    Paxton, JW
    DRUG METABOLISM REVIEWS, 2003, 35 (01) : 35 - 98
  • [4] Cannabinoids and Cytochrome P450 Interactions
    Zendulka, Ondrej
    Dovrtelova, Gabriela
    Noskova, Kristyna
    Turjap, Miroslav
    Sulcova, Alexandra
    Hanus, Lumir
    Jurica, Jan
    CURRENT DRUG METABOLISM, 2016, 17 (03) : 206 - 226
  • [5] Cytochrome P450: Structure and interactions - Foreword
    Hon, GHB
    BIOCHIMIE, 1996, 78 (8-9) : 683 - 684
  • [6] Studies on cytochrome P450 reductase interactions
    Korzekwa, KR
    Shou, M
    Grogan, J
    Parise, R
    FASEB JOURNAL, 1997, 11 (09): : A771 - A771
  • [7] Role of cytochrome P450 in drug interactions
    Zakia Bibi
    Nutrition & Metabolism, 5
  • [8] Cytochrome P450 structures and their substrate interactions
    Lewis, DFV
    Ito, Y
    Goldfarb, PS
    DRUG DEVELOPMENT RESEARCH, 2005, 66 (01) : 19 - 24
  • [9] Interactions of mammalian cytochrome P450, NADPH-cytochrome P450 reductase, and cytochrome b5 enzymes
    Shimada, T
    Mernaugh, RL
    Guengerich, FP
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2005, 435 (01) : 207 - 216
  • [10] Immobilized Cytochrome P450 for Monitoring of P450-P450 Interactions and Metabolisms
    Bostick, Chris D.
    Hickey, Katherine M.
    Wollenberg, Lance A.
    Flora, Darcy R.
    Tracy, Timothy S.
    Gannett, Peter M.
    DRUG METABOLISM AND DISPOSITION, 2016, 44 (05) : 741 - 749